SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.28), $0.06 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $15.86 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2024 revenue of $65-67 million, versus the consensus of $65.82 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.